Targeted Cancer Therapy
Sanjay dives into the mechanics of Herceptin, a targeted therapy that specifically attacks the HER2 receptor, offering a more precise approach compared to traditional chemotherapy. This method not only minimizes damage to healthy cells but also leads to higher survival rates for patients with HER2 positive breast cancer. The conversation highlights the importance of trust in modern medicine and the liberation felt by patients when they see effective results from their treatment.In this clip
From this podcast
Keeping It Real: Conversations with Jillian Michaels
Understanding Cancer & the Latest Scientific Breakthroughs to Reduce Risk / Cure It, with Dr. Sanjay Juneja
Related Questions